This topic contains a solution. Click here to go to the answer

Author Question: A comparison of functional residual capacity measured by body plethysmography with that measured by ... (Read 83 times)

tsand2

  • Hero Member
  • *****
  • Posts: 520
A comparison of functional residual capacity measured by body plethysmography with that measured by
 
  nitrogen washout reveals that the measurement obtained during the nitrogen washout test is less than that during body plethysmography. This discrepancy is most likely caused by which of the following?
  a. Poor technique c. Restrictive lung disease
  b. Severe air-trapping d. Directional valve malfunction

Question 2

The standard for repeatability for forced expiratory volume in 1 second (FEV1) is ___ mL.
 
  a. 100 c. 200
  b. 150 d. 250



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tandmlomax84

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

ANS: B
Severe air-trapping will produce lower functional residual capacity results than body plethys-mography because the nitrogen washout test measures gas volumes only in communicating air-ways.

Answer to Question 2

ANS: B
The repeatability standard for FEV1 is 150 mL.




tsand2

  • Member
  • Posts: 520
Reply 2 on: Jul 16, 2018
Excellent


coreycathey

  • Member
  • Posts: 333
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

There are more bacteria in your mouth than there are people in the world.

For a complete list of videos, visit our video library